AAAAAA

   
Results: 1-25 | 26-50 | 51-75 | 76-100 | >>
Results: 76-100/112

Authors: Talley, NJ Janssens, J Lauritsen, K Racz, I Bolling-Sternevald, E
Citation: Nj. Talley et al., Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up, BR MED J, 318(7187), 1999, pp. 833-837

Authors: Howell, S Talley, NJ
Citation: S. Howell et Nj. Talley, Does fear of serious disease predict consulting behaviour amongst patientswith dyspepsia in general practice?, EUR J GASTR, 11(8), 1999, pp. 881-886

Authors: Kalantar, JS Talley, NJ
Citation: Js. Kalantar et Nj. Talley, The effects of lottery incentive and length of questionnaire on health survey response rates: A randomized study, J CLIN EPID, 52(11), 1999, pp. 1117-1122

Authors: Talley, NJ
Citation: Nj. Talley, Management of dyspepsia and functional dyspepsia: An international perspective, CAN J GASTR, 13(8), 1999, pp. 685-687

Authors: Talley, NJ Axon, A Bytzer, P Holtmann, G Lam, SK van Zanten, SV
Citation: Nj. Talley et al., Management of uninvestigated and functional dyspepsia: a working party report for the World Congresses of Gastroenterology 1998, ALIM PHARM, 13(9), 1999, pp. 1135-1148

Authors: Talley, NJ Chang, FY Wyatt, JMA Adams, S Lau, A Borody, T Chen, TS Daskolopolos, G Cheung, K Talley, NA
Citation: Nj. Talley et al., Nizatidine in combination with amoxycillin and clarithromycin in the treatment of Helicobacter pylori infection. (vol 12, pg 527, 1998), ALIM PHARM, 13(6), 1999, pp. 841-841

Authors: Hammer, J Talley, NJ
Citation: J. Hammer et Nj. Talley, Nonulcer dyspepsia, CURR OPIN G, 15(6), 1999, pp. 492-496

Authors: Bensoussan, A Talley, NJ Menzies, R
Citation: A. Bensoussan et al., Chinese herbal medicine for irritable bowel syndrome - Reply, J AM MED A, 282(11), 1999, pp. 1036-1037

Authors: Kalantar, J Eslick, GD Talley, NJ
Citation: J. Kalantar et al., Chronic gastritis and nonulcer dyspepsia, CURR T MICR, 241, 1999, pp. 31-45

Authors: Talley, NJ
Citation: Nj. Talley, Helicobacter pylori and dyspepsia, YALE J BIOL, 72(2-3), 1999, pp. 145-151

Authors: Meineche-Schmidt, V Talley, NJ Pap, A Kordecki, H Schmid, V Ohlsson, L Wahlqvist, P Wiklund, I Bolling-Sternevald, E
Citation: V. Meineche-schmidt et al., Impact of functional dyspepsia on quality of life and health care consumption after cessation of antisecretory treatment - A multicentre 3-month follow-up study, SC J GASTR, 34(6), 1999, pp. 566-574

Authors: Nandurkar, S Talley, NJ
Citation: S. Nandurkar et Nj. Talley, Gastroesophageal reflux and adenocarcinoma of the esophagus, N ENG J MED, 341(7), 1999, pp. 536-536

Authors: Talley, NJ Vakil, N Ballard, ED Fennerty, MB
Citation: Nj. Talley et al., Absence of benefit of eradicating Helicobacter pylori in patients with nonulcer dyspepsia, N ENG J MED, 341(15), 1999, pp. 1106-1111

Authors: Blum, AL Talley, NJ Stolte, M
Citation: Al. Blum et al., Helicobacter pylori and nonulcer dyspepsia, N ENG J MED, 340(19), 1999, pp. 1510-1511

Authors: Talley, NJ Stanghellini, V Heading, RC Koch, KL Malagelada, JR Tytgat, GNJ
Citation: Nj. Talley et al., Functional gastroduodenal disorders, GUT, 45, 1999, pp. 37-42

Authors: van Zanten, SJOV Talley, NJ Bytzer, P Klein, KB Whorwell, PJ Zinsmeister, AR
Citation: Sjov. Van Zanten et al., Design of treatment trials for functional gastrointestinal disorders, GUT, 45, 1999, pp. 69-77

Authors: Talley, NJ
Citation: Nj. Talley, How should Helicobacter pylori positive dyspeptic patients be managed?, GUT, 45, 1999, pp. I28-I31

Authors: Dent, J Brun, J Fendrick, AM Fennerty, MB Janssens, J Kahrilas, PJ Lauritsen, K Reynolds, JC Shaw, M Talley, NJ
Citation: J. Dent et al., An evidence-based appraisal of reflux disease management - the Genval workshop report, GUT, 44, 1999, pp. S1-S16

Authors: Haag, S Nandurkar, S Talley, NJ
Citation: S. Haag et al., Regression of Barrett's esophagus: the role of acid suppression, surgery, and ablative methods, GASTROIN EN, 50(2), 1999, pp. 229-240

Authors: Xia, HHX Talley, NJ
Citation: Hhx. Xia et Nj. Talley, Helicobacter pylori eradication in patients with non-ulcer dyspepsia, DRUGS, 58(5), 1999, pp. 785-792

Authors: Oliveria, SA Christos, PJ Talley, NJ Dannenberg, AJ
Citation: Sa. Oliveria et al., Heartburn risk factors, knowledge, and prevention strategies - A population-based survey of individuals with heartburn, ARCH IN MED, 159(14), 1999, pp. 1592-1598

Authors: Locke, GR Talley, NJ Fett, SL Zinsmeister, AR Melton, LJ
Citation: Gr. Locke et al., Risk factors associated with symptoms of gastroesophageal reflux, AM J MED, 106(6), 1999, pp. 642-649

Authors: Eslick, GD Lim, LLY Byles, JE Xia, HHX Talley, NJ
Citation: Gd. Eslick et al., Association of Helicobacter pylori infection with gastric carcinoma: A meta-analysis, AM J GASTRO, 94(9), 1999, pp. 2373-2379

Authors: Talley, NJ Verlinden, M Jones, M
Citation: Nj. Talley et al., Validity of a new quality of life scale for functional dyspepsia: a UnitedStates multicenter trial of the Nepean Dyspepsia Index, AM J GASTRO, 94(9), 1999, pp. 2390-2397

Authors: Nandurkar, S Talley, NJ
Citation: S. Nandurkar et Nj. Talley, Barrett's esophagus: The long and the short of it (vol 94, pg 30, 1999), AM J GASTRO, 94(6), 1999, pp. 1719-1719
Risultati: 1-25 | 26-50 | 51-75 | 76-100 | >>